{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:28:46Z","timestamp":1791152926604,"version":"4.1.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1888,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,7]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>We prospectively investigated 615,532 diabetic patients and 614,871 age-matched and sex-matched control subjects selected from National Health Insurance claims for malignant neoplasms of liver and biliary tract (International Statistical Classification of Diseases and Related Health Problems, 9th edition, codes 155 and 156, respectively) between 2000 and 2006. The person-year approach with Poisson assumption was used to estimate the hazard rates. We also evaluated the age-specific and sex-specific relative risks of these two malignancies in relation to diabetes with Cox proportional hazard regression model with adjustment for potential confounders. The overall hazard rate of malignant neoplasm of the liver was 32.76 and 17.41 per 10,000 patient-years, respectively, for diabetic men and women; the corresponding figures for biliary tract neoplasm were much lower at 1.42 and 1.60 per 10,000 patient-years. Compared with control subjects, diabetic patients had a two-fold increased risk of malignant neoplasm of the liver, but this risk was attenuated by adjusting for selected clinical risk factors (hazard ratio [HR] 1.21; 95% confidence interval [CI] 1.17-1.25). Additionally, diabetic patients were associated with increased risk of biliary neoplasms with an approximate magnitude of 20%-30%, but the HR was attenuated and became insignificant after adjustment for clinical risk factors (HR 1.07; 95% CI 0.95-1.21). Diabetic patients with cirrhosis had the highest relative risk of liver neoplasm (HR 85.25; 95% CI 76.84-94.58), whereas those with cholangitis had the highest risk of biliary tract neoplasm (HR 70.30; 95% CI 51.95-95.12) compared with control subjects without any clinical risk factors.<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>\n                                 <jats:bold>This population-based study confirms the association of diabetes with liver neoplasm and suggests that diabetic patients with certain clinical risk factors should be educated for strict adherence of liver neoplasm screening. (Hepatology 2010)<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.23641","type":"journal-article","created":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T20:26:13Z","timestamp":1267475173000},"page":"155-163","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":80,"title":["Risk of Malignant Neoplasms of Liver and Biliary Tract in Diabetic Patients With Different Age and Sex Stratifications"],"prefix":"10.1097","volume":"52","author":[{"given":"Hua-Fen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-17-20250312","first-page":"10471053","article-title":"Global prevalence of diabetes: estimated for the year 2000 and projections for 2030.","volume":"27","author":"Wild","year":"2004","journal-title":"Diabetes Care"},{"key":"R4-17-20250312","doi-asserted-by":"crossref","first-page":"18201826","DOI":"10.1093\/jnci\/83.24.1820","article-title":"Nonviral risk factors for hepatocellular carcinoma in a lowrisk population, the NonAsians of Los Angeles County, California.","volume":"83","author":"Yu","year":"1991","journal-title":"J Natl Cancer Inst"},{"key":"R5-17-20250312","doi-asserted-by":"crossref","first-page":"14721477","DOI":"10.1093\/jnci\/88.20.1472","article-title":"Excessive risk of primary liver cancer in patients with diabetes mellitus.","volume":"88","author":"Adami","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"R6-17-20250312","doi-asserted-by":"crossref","first-page":"629634","DOI":"10.1016\/S0959-8049(96)00500-X","article-title":"Attributable risk for hepatocellular carcinoma in Northern Italy.","volume":"33","author":"Braga","year":"1997","journal-title":"Eur J Cancer"},{"key":"R7-17-20250312","doi-asserted-by":"crossref","first-page":"204207","DOI":"10.1002\/(SICI)1097-0215(19971009)73:2<204::AID-IJC7>3.0.CO;2-#","article-title":"Diabetes mellitus and the risk of primary liver cancer.","volume":"73","author":"La Vecchia","year":"1997","journal-title":"Int J Cancer"},{"key":"R8-17-20250312","doi-asserted-by":"crossref","first-page":"13601365","DOI":"10.1093\/jnci\/89.18.1360","article-title":"Cancer incidence in a populationbased cohort of patients hospitalized with diabetes mellitus in Denmark.","volume":"89","author":"Wideroff","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"R9-17-20250312","doi-asserted-by":"crossref","first-page":"10961099","DOI":"10.1093\/jnci\/92.13.1096","article-title":"Role of diabetes mellitus in the etiology of hepatocellular carcinoma.","volume":"92","author":"Lagiou","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R10-17-20250312","first-page":"24622467","article-title":"The role of diabetes in hepatocellular carcinoma: a casecontrol study among United States veterans.","volume":"96","author":"ElSerag","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R11-17-20250312","doi-asserted-by":"crossref","first-page":"12061213","DOI":"10.1053\/jhep.2002.36780","article-title":"Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus.","volume":"36","author":"Hassan","year":"2002","journal-title":"Hepatology"},{"key":"R12-17-20250312","doi-asserted-by":"crossref","first-page":"10091017","DOI":"10.1002\/cncr.20427","article-title":"Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the US.","volume":"101","author":"Yuan","year":"2004","journal-title":"Cancer"},{"key":"R13-17-20250312","first-page":"460468","article-title":"Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma.","volume":"126","author":"Elserag","year":"2004","journal-title":"Gastroenetrology"},{"key":"R14-17-20250312","doi-asserted-by":"crossref","first-page":"533539","DOI":"10.1136\/gut.2004.052167","article-title":"Diabetes increases the risk of hepatocellular carcinoma in the United States: a populationbased case control study.","volume":"54","author":"Davila","year":"2005","journal-title":"Gut"},{"key":"R15-17-20250312","doi-asserted-by":"crossref","first-page":"194202","DOI":"10.1001\/jama.293.2.194","article-title":"Fasting serum glucose level and cancer risk in Korean men and women.","volume":"293","author":"Jee","year":"2005","journal-title":"JAMA"},{"key":"R17-17-20250312","doi-asserted-by":"crossref","first-page":"12951302","DOI":"10.1002\/hep.21208","article-title":"Type 2 diabetes and hepatocellular carcinoma: a cohort study in high prevalence area of hepatitis virus infection.","volume":"43","author":"Lai","year":"2006","journal-title":"Hepatology"},{"key":"R18-17-20250312","doi-asserted-by":"crossref","first-page":"8389","DOI":"10.1097\/01.cej.0000228404.37858.40","article-title":"Diabetes and cancer risk of all and specific sites among Japanese men and women.","volume":"16","author":"Kuriki","year":"2007","journal-title":"Eur J Cancer Prev"},{"key":"R19-17-20250312","doi-asserted-by":"crossref","first-page":"12211228","DOI":"10.1016\/j.cgh.2007.05.020","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a populationbased casecontrol study.","volume":"5","author":"Welzel","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R20-17-20250312","doi-asserted-by":"crossref","first-page":"178180","DOI":"10.1038\/sj.bjc.6604765","article-title":"The antecedents of biliary cancer: a primary casecontrol study in the United Kingdom.","volume":"100","author":"Grainge","year":"2009","journal-title":"Br J Cancer"},{"key":"R21-17-20250312","doi-asserted-by":"crossref","first-page":"561567","DOI":"10.2337\/dc06-0922","article-title":"Prospective study of hyperglycemia and cancer risk.","volume":"30","author":"Stattin","year":"2007","journal-title":"Diabetes Care"},{"key":"R23-17-20250312","doi-asserted-by":"crossref","first-page":"7788","DOI":"10.1377\/hlthaff.22.3.77","article-title":"Does Universal health insurance make health care unaffordable? Lessons from Taiwan.","volume":"22","author":"Lu","year":"2003","journal-title":"Health Aff"},{"key":"R24-17-20250312","doi-asserted-by":"crossref","first-page":"225239","DOI":"10.1016\/S0168-8510(96)00877-9","article-title":"Taiwans 1995 healthcare reform.","volume":"39","author":"Chiang","year":"1997","journal-title":"Health Policy"},{"key":"R26-17-20250312","doi-asserted-by":"crossref","first-page":"24092414","DOI":"10.2337\/dc06-1343","article-title":"Age and sex may significantly interact with diabetes on the risk of lowerextremity amputation and peripheral revascularization procedures: evidence from a cohort of a halfmillion diabetic patients.","volume":"29","author":"Chen","year":"2006","journal-title":"Diabetes Care"},{"key":"R28-17-20250312","doi-asserted-by":"crossref","first-page":"487493","DOI":"10.1016\/S0895-4356(02)00605-4","article-title":"Geographic variation within the United States in the incidence of hepatocellular carcinoma.","volume":"56","author":"Davila","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"R29-17-20250312","first-page":"280288","article-title":"Liver cirrhosis and diabetes; risk factors, pathophysiology, clinical implications and management.","volume":"15","author":"GarciaCompean","year":"2009","journal-title":"World J Gastroenterol"},{"key":"R30-17-20250312","doi-asserted-by":"crossref","first-page":"827834","DOI":"10.1097\/MEG.0b013e3282748ef2","article-title":"Primary liver cancer with nonalcoholic staetohepatitis.","volume":"19","author":"Hashizume","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R32-17-20250312","doi-asserted-by":"crossref","first-page":"146152","DOI":"10.1016\/S1726-4901(09)70195-9","article-title":"Seroprevalence of hepatitis B and C in type 2 diabetic patients.","volume":"69","author":"Chen","year":"2006","journal-title":"J Chin Med Assoc"},{"key":"R33-17-20250312","first-page":"733746","article-title":"The global impact of hepatic fibrosis and endstage liver disease.","volume":"12","author":"Lim","year":"2008","journal-title":"Chr Liver Dis"},{"key":"R34-17-20250312","doi-asserted-by":"crossref","first-page":"254258","DOI":"10.2337\/dc06-0997","article-title":"Increased cancerrelated mortality for patients with type 2 diabetes who use sulphonylureas or insulin.","volume":"29","author":"Bowker","year":"2006","journal-title":"Diabetes Care"},{"key":"R36-17-20250312","doi-asserted-by":"crossref","first-page":"55765582","DOI":"10.1200\/JCO.2008.16.1075","article-title":"Bodymass index and progression of hepatitis B: a populationbased cohort study in men.","volume":"26","author":"Yu","year":"2008","journal-title":"J Clin Oncol"},{"key":"R37-17-20250312","doi-asserted-by":"crossref","first-page":"421430","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1053>3.0.CO;2-T","article-title":"Overweight as an avoidable cause of cancer in Europe.","volume":"91","author":"Bergstrom","year":"2001","journal-title":"Int J Cancer"},{"key":"R38-17-20250312","doi-asserted-by":"crossref","first-page":"844850","DOI":"10.7326\/0003-4819-119-8-199310150-00011","article-title":"Discordance of databases designed for claims payment versus clinical information systems: implications for outcomes research.","volume":"119","author":"Jollis","year":"1993","journal-title":"Ann Intern Med"},{"key":"R39-17-20250312","first-page":"157163","article-title":"Accuracy of diabetes diagnosis in health insurance claims data in Taiwan.","volume":"104","author":"Lin","year":"2005","journal-title":"J Formos Med Assoc"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.23641","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201007000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T11:01:34Z","timestamp":1741777294000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201007000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.23641","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}